Skip to main content
Top
Published in: Supportive Care in Cancer 6/2004

01-06-2004 | Review Article

The treatment of lymphedema related to breast cancer: a systematic review and evidence summary

Authors: Lyn Kligman, Rebecca K. S. Wong, Mary Johnston, Nancy S. Laetsch, Members of the Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-based Care

Published in: Supportive Care in Cancer | Issue 6/2004

Login to get access

Abstract

Goals of work

To provide an evidence summary report on the question: What are the treatment options for women with lymphedema following treatment for breast cancer?

Methods

Cancer Care Ontario’s Supportive Care Guidelines Group (SCGG) employed systematic review methodology to produce an evidence summary on this topic. Evidence-based opinions were formulated to guide clinical decision making, and a formal external review process was conducted to validate the relevance of these opinions for Ontario practitioners.

Results

The systematic review search strategy identified ten randomized controlled trials which form the basis of this evidence summary report. Four key opinions offered by the SCGG are outlined below. Responses from the practitioner feedback process supported the validity of these opinions in Ontario. (1) There is some evidence to suggest that compression therapy and manual lymphatic drainage may improve established lymphedema, but further studies are needed. Compression garments should be worn from morning to night and be removed at bedtime. Patients should be advised that lymphedema is a lifelong condition and that compression garments must be worn on a daily basis. Patients can expect stabilization and/or modest improvement of edema with the use of the garment in the prescribed fashion. (2) There is no current evidence to support the use of medical therapies, including diuretics. (3) Additional efforts to define relevant clinical outcomes for the assessment of patients with lymphedema would be valuable. (4) These opinions are appropriate for patients with more than mild lymphedema, where the signs and symptoms are considered significant from the patients’ perspective.
Footnotes
1
Two additional clinical practice guidelines, one by the New Zealand Guidelines Group (NZGG) on surgical management of breast cancer, and one by the National Breast Cancer Centre in Australia on management of early breast cancer surgery, were identified online at the time of our search but are no longer electronically accessible.
 
Literature
1.
go back to reference Anderson L, Hojris I, Erlandsen M, et al (2000) Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage: a randomized study. Acta Oncol 39:399–405CrossRefPubMed Anderson L, Hojris I, Erlandsen M, et al (2000) Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage: a randomized study. Acta Oncol 39:399–405CrossRefPubMed
2.
go back to reference Badger C, Seers K, Preston N, et al (2002) Physical therapies for reducing and controlling lymphoedema of the limbs (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, Oxford Badger C, Seers K, Preston N, et al (2002) Physical therapies for reducing and controlling lymphoedema of the limbs (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, Oxford
3.
go back to reference Bertelli G, Venturini M, Forno G, et al (1991) Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. Ann Oncol 2:575–578 Bertelli G, Venturini M, Forno G, et al (1991) Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. Ann Oncol 2:575–578
4.
go back to reference Blanchard DK, Donohue JH, Reynolds C, et al (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–487CrossRefPubMed Blanchard DK, Donohue JH, Reynolds C, et al (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–487CrossRefPubMed
5.
go back to reference Browman GP, Levine MN, Mohide EA, et al (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502–512PubMed Browman GP, Levine MN, Mohide EA, et al (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502–512PubMed
6.
go back to reference Browning C (1997) The management of lymphoedema. In: Redman S, Pillar C, Turner J, Boyle F (eds) Lymphoedema: prevalence, risk factors and management: a review of research. NHMRC National Breast Cancer Centre, Sydney Browning C (1997) The management of lymphoedema. In: Redman S, Pillar C, Turner J, Boyle F (eds) Lymphoedema: prevalence, risk factors and management: a review of research. NHMRC National Breast Cancer Centre, Sydney
7.
go back to reference Casley-Smith JR, Morgan RG, Piller NB (1993) Treatment of lymphedema of the arms and legs with 5,6-benzo-pyrone. N Engl J Med 329:1158–1163CrossRefPubMed Casley-Smith JR, Morgan RG, Piller NB (1993) Treatment of lymphedema of the arms and legs with 5,6-benzo-pyrone. N Engl J Med 329:1158–1163CrossRefPubMed
8.
go back to reference Dini D, Del Mastro L, Gozz A, et al (1998) The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol 9:187–191 Dini D, Del Mastro L, Gozz A, et al (1998) The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol 9:187–191
9.
go back to reference Erickson VS, Pearson ML, Ganz PA, et al (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111CrossRefPubMed Erickson VS, Pearson ML, Ganz PA, et al (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111CrossRefPubMed
10.
go back to reference Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMed Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMed
11.
go back to reference Harris SR, Hugi MR, Olivotto IA, et al, for the Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 164:191–199PubMed Harris SR, Hugi MR, Olivotto IA, et al, for the Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 164:191–199PubMed
12.
go back to reference Hoe AL, Iven D, Royle GT, et al (1992) Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79:261–262PubMed Hoe AL, Iven D, Royle GT, et al (1992) Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79:261–262PubMed
13.
go back to reference Hornsby R (1995) The use of compression to treat lymphoedema. Prof Nurs 11:127–128 Hornsby R (1995) The use of compression to treat lymphoedema. Prof Nurs 11:127–128
14.
go back to reference Howell D, Ezzo J, Tuppo K, et al (2002) Complete decongestive therapy for lymphedema following breast cancer treatment (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, Oxford Howell D, Ezzo J, Tuppo K, et al (2002) Complete decongestive therapy for lymphedema following breast cancer treatment (Protocol for a Cochrane Review). In: The Cochrane Library, issue 2. Update Software, Oxford
15.
go back to reference Jacobson JS, Workman SB, Kronenberg F (2000) Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 18:668–683PubMed Jacobson JS, Workman SB, Kronenberg F (2000) Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol 18:668–683PubMed
16.
go back to reference Jani AB, Basu A, Heimann R, et al (2003) Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis. Cancer 97:359–366CrossRefPubMed Jani AB, Basu A, Heimann R, et al (2003) Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis. Cancer 97:359–366CrossRefPubMed
17.
go back to reference Johansson K, Lie E, Ekdahl C, et al (1998) A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology 31:56–64PubMed Johansson K, Lie E, Ekdahl C, et al (1998) A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology 31:56–64PubMed
18.
go back to reference Kissin MW, Querci della Roveret G, Easton D, et al (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:680–684 Kissin MW, Querci della Roveret G, Easton D, et al (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:680–684
19.
go back to reference Logan V (1995) Incidence and prevalence of lymphedema: a literature review. J Clin Nurs 4:213–219PubMed Logan V (1995) Incidence and prevalence of lymphedema: a literature review. J Clin Nurs 4:213–219PubMed
20.
go back to reference Loprinzi CL, Kugler JW, Sloan JA, et al (1999) Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340:346–350CrossRefPubMed Loprinzi CL, Kugler JW, Sloan JA, et al (1999) Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340:346–350CrossRefPubMed
21.
go back to reference Markowski J, Wilcox J, Helm P (1981) Lymphedema incidence after specific postmastectomy therapy. Arch Phys Med Rehabil 62:449–452PubMed Markowski J, Wilcox J, Helm P (1981) Lymphedema incidence after specific postmastectomy therapy. Arch Phys Med Rehabil 62:449–452PubMed
22.
go back to reference Megens A, Harris SR (1998) Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther 78:1302–1311PubMed Megens A, Harris SR (1998) Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther 78:1302–1311PubMed
23.
go back to reference Oncology Nursing Society (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Press, Pittsburgh, PA (summary at http://www.ons.org/xp6/ONS/Library.xml/ONS_Publications.xml/Book_Excerpts.xml/ManualRadiationOncology/FrontPage.xml) Oncology Nursing Society (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Press, Pittsburgh, PA (summary at http://​www.​ons.​org/​xp6/​ONS/​Library.​xml/​ONS_​Publications.​xml/​Book_​Excerpts.​xml/​ManualRadiationO​ncology/​FrontPage.​xml)
24.
go back to reference Pain SJ, Purushotham AD (2000) Lymphoedema following surgery for breast cancer. Br J Surg 87:1128–1141 Pain SJ, Purushotham AD (2000) Lymphoedema following surgery for breast cancer. Br J Surg 87:1128–1141
25.
go back to reference Pecking A, Lasry S, Boudinet A, et al (1988) Post surgical physiotherapeutic treatment: interest in secondary upper limb lymphedemas prevention. Prog Lymphology 11:562–564 Pecking A, Lasry S, Boudinet A, et al (1988) Post surgical physiotherapeutic treatment: interest in secondary upper limb lymphedemas prevention. Prog Lymphology 11:562–564
26.
go back to reference Pecking AP, Fevrier B, Wargon C, et al (1997) Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 48:93–98PubMed Pecking AP, Fevrier B, Wargon C, et al (1997) Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 48:93–98PubMed
27.
go back to reference Piller NB, Morgan RG, Casley-Smith JR (1988) A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzopyrones) in the treatment of the arms and legs. Br J Plast Surg 41:20–27PubMed Piller NB, Morgan RG, Casley-Smith JR (1988) A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzopyrones) in the treatment of the arms and legs. Br J Plast Surg 41:20–27PubMed
28.
go back to reference Ramos SM, O’Donnell LS, Knight G (1999) Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg 178:311–315CrossRefPubMed Ramos SM, O’Donnell LS, Knight G (1999) Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg 178:311–315CrossRefPubMed
29.
go back to reference Schijven MP, Vingerhoets AJ, Rutten HJ, et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350CrossRefPubMed Schijven MP, Vingerhoets AJ, Rutten HJ, et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350CrossRefPubMed
30.
go back to reference Scottish Intercollegiate Guidelines Network (1998) Breast cancer in women (publication no. 29). http://www.show.scot.nhs.uk/sign/guidelines/fulltext/29/index.html Scottish Intercollegiate Guidelines Network (1998) Breast cancer in women (publication no. 29). http://​www.​show.​scot.​nhs.​uk/​sign/​guidelines/​fulltext/​29/​index.​html
Metadata
Title
The treatment of lymphedema related to breast cancer: a systematic review and evidence summary
Authors
Lyn Kligman
Rebecca K. S. Wong
Mary Johnston
Nancy S. Laetsch
Members of the Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-based Care
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0627-0

Other articles of this Issue 6/2004

Supportive Care in Cancer 6/2004 Go to the issue

Forthcoming Meetings

June 2004

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine